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This article refers to ‘Telemonitoring versus stan-
dard care in heart failure: a randomised multicentre
trial’ by M. Galinier et al., published in this issue on
pages 985–994.
Never let a ‘good’ crisis go to waste!
(attributed by some to Winston Churchill on planning
to set up the United Nations during World War II)
In this issue of the Journal, Galinier et al.1 report a randomised trial
of care supported by home telemonitoring including almost 1000
patients with heart failure. Telemonitoring consisted of questions
about symptoms and daily weights. Data were relayed to a secure
server, which generated alerts, to which nurses responded, during
routine working hours, by advising patients whether they should
contact their family practitioner or cardiologist. Compliance with
measuring weight was often poor. We are not told how many
patients contacted a doctor, what advice they received, or whether
they complied with it. This complex chain of communication is only
as strong as its weakest link.
The trial was neutral for its composite primary endpoint,
unplanned hospitalisation for heart failure or all-cause mortality
(rate ratio 0.97; P = 0.80), and for all pre-specified secondary end-
points. A further analysis, focussing on first unplanned hospitali-
sation for heart failure, suggested a modest improvement (hazard
ratio 0.79; P = 0.044), that was driven by larger effects in those
who weighed themselves regularly or had greater functional limita-
tion or who were more socially isolated. Some will view this trial as
further evidence that home telemonitoring is ineffective for heart
failure, ignoring the overall positive effect identified by systematic
reviews.2–4 Others will suggest the trial was neutral because of
inadequate technology, lack of a robust and timely response to
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. alerts, insufficient patient motivation and the problems inherent
in conducting trials of service re-design. Ultimately, a system that
is cost-efficient, user-friendly and person-centred does not need
to show that it improves outcome; it only needs to show that it
is not inferior to traditional ways of delivering care.5 Now, more
than ever, this evidence is reassuring.
The COVID-19 pandemic is now revolutionising attitudes to
remote patient follow-up; widespread scepticism has switched to
near-universal enthusiasm and rapid adoption into routine care.6
The drive comes from both health professionals and patients, who
want to comply with social distancing whilst ensuring continued
delivery of good healthcare. This applies especially to patients with
heart failure. In retrospect, it is a great shame that home telemon-
itoring was not already routine before the pandemic struck. This
would have saved billions of healthcare ‘dollars’ worldwide as well
as the stress of rapidly implementing telehealth without established
infrastructure or protocols. Preparing for, rather than reacting
to, a crisis seems wise, but is it rational to configure healthcare
for non-communicable diseases in future decades around the
risk of pandemic infections? Perhaps not, unless there are other
advantages to telecare.
All those involved in telemonitoring must be motivated to
support the service, most importantly the patient. Patient attitudes
have changed hugely with the advent of the COVID-19 pandemic;
many are refusing to come to a healthcare facility, in primary or
secondary care, even if they are unwell. Many are now eager to have
healthcare delivered at home. Although some may not cope with
the technology, most will have a family member or carer who can.
Ultimately, home telemonitoring will not work for every patient
but if it works for some, then resources can be targeted more
effectively for all.
© 2020 The Authors. European Journal of Heart Failure published by John Wiley & Sons Ltd on behalf of European Society of Cardiology.
This is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in
any medium, provided the original work is properly cited.
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The technology must be easy to install, intuitive to users and
provide robust communication. Achieving uniformity across tele-
health platforms for healthcare providers and medical specialities
would be a bonus for patients; using a different system to manage
each of a patient’s medical problems is confusing, costly and
impractical. Smartphones are widely available in high-, middle- and
most low-income countries and solve many of these problems.
Multi-user systems in care homes or community tele-kiosks can
make even more efficient use of equipment when social distancing
is not possible or not required. Voice interactive systems annoy
many people and should be avoided until they can deal with local
dialects. Devices should connect to systems wirelessly. Systems
should provide a flexible set of modules that can be aligned to
the patient’s medical needs, commonly including hypertension,
diabetes, coronary artery disease, atrial fibrillation, lung disease,
renal dysfunction, heart failure, and mental health. Perhaps every-
one with a chronic disease or everyone of retirement age should
be offered telemonitoring. Ultimately, telehealth could become
another standard household utility, just like electricity, gas, or the
internet, providing education and trusted advice for people of all
ages. Where healthcare is provided by the State or an insurance
company, provision of the internet and telehealth should attract
no additional cost to the patient. Better to have immediate triage
by telehealth to the need for and most appropriate healthcare
provider, whether that is a pharmacist, physiotherapist, family prac-
titioner or specialist, rather than waiting days for an appointment
before sitting in a waiting room for hours for a 5-min consultation
with a doctor, only to be referred on to someone else. What
would you prefer?
Most routine healthcare can be automated. For problems such
hypertension and atrial fibrillation, patients can do non-invasive
checks, which can be fed into their electronic health record,
where guideline-driven algorithms can advise the patient and local
pharmacy about which tests and treatments are required. For
patients who already have a device implant, such as a loop recorder,
pacemaker, defibrillator or pulmonary artery pressure monitor,
even more information can be obtained. A doctor needs only
enter the healthcare loop when required. Doctors and nurses
should facilitate such automation rather than be sceptical and a
barrier to efficient care. Physical contact may be more important
for the psychology of health professionals than for patients, who
may just want good care from someone they trust and can access
without needing to wait weeks or months for an appointment.
Clearly, some people will prefer more traditional forms of care and,
for the complex cases that algorithms cannot currently manage,
consultations may take longer. Rapid adoption of telehealth during
the pandemic has created an opportunity to re-design how care is
delivered and by whom (mainly patients) that should be grasped.
Many trials of telemonitoring for heart failure have attempted
to predict and manage episodes of decompensation; this ‘crisis
management’ strategy has produced inconclusive results.7 The
high rate of false-positive alerts is its Achilles’ heel. Rather than
trying to detect something going wrong and fixing it, a ‘health
maintenance’ strategy declares an ideal target for an individual and
adjusts treatment to maintain them as close to ideal as possible.
This strategy avoids the problem of false alerts and involves the ..
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.. patient more closely in their care. Better control of congestion
will have favourable effects of atrial and ventricular remodelling,
arrhythmias and pulmonary hypertension, which should improve
prognosis.8–10 A health maintenance strategy can be personalised
and delivered by a friendly, local healthcare team. Data from
hundreds of patients can be managed by automated systems,
requiring staff input for only a few hours per week and can
readily be integrated with physical visits in the community or
hospital. Remote monitoring does not have to mean remote
care. A crisis management strategy requires a 24 h, 7-day per
week service. This might be manageable at a regional or national
level but too expensive for local services, unless delivered as an
extension of existing facilities such as coronary care units. The
two approaches are not mutually exclusive, but the former is likely
to be the more feasible and cost-effective component.11 Patients
often get bored with telemonitoring systems that provide no
feedback and do not seem to ‘do’ anything. A health maintenance
strategy provides much greater patient engagement and motivation
through both education and patient action.12,13 Educating patients,
empathetically, about what treatment targets should be achieved,
whether that is weight, heart rate or blood pressure, empowers
them to participate in the development and delivery of care.
Patients who are unaware of their care plan may struggle to help
doctors deliver it. Telemonitoring can deliver health education in
many formats; infographics, videos, gaming, quizzes, and inform
patients of what tests they need and why and when. Measurements
can also be used to determine daily doses of diuretics and some
other medications.14 The habit of giving the same diuretic dose
every day arises from the lack of resources and technology to
monitor requirements.
Telemonitoring should be time efficient. Dentists recommend
that people should spend at least 2 min twice a day brushing their
teeth. A cardiovascular health check takes less time. Daily checks
are probably not required for stable patients; text reminders can be
scheduled less often. The focus should be on acquiring therapeu-
tically actionable data, such as symptoms, heart rate and rhythm,
weight, or more sophisticated measurements of congestion if avail-
able (Table 1). Pulse oximetry might be useful for managing res-
piratory disease including COVID-19 infections of intermediate
severity. Haematocrit, serum potassium and creatinine are action-
able but no reliable, affordable method of home measurement
currently exists, but technology is being developed. Local phle-
botomy services, with home visits if necessary, would be a simple
and inexpensive alternative. Video-consultation can often replace
clinic visits. Indeed, armed with a wealth of patient-recorded infor-
mation, linked to electronic healthcare records and supported by
machine-learning algorithms, the consultation, for both patient and
health professional, may be more rewarding than a physical visit.
However, video-consultation is time-consuming and probably not
the most effective or efficient way that telemonitoring can support
patient self-management.
There are other important consequences of switching from a
traditional model of care. Home telemonitoring enables patients
to be part of the workforce, delivering truly individualised
healthcare.15 Even in countries with ostensibly free healthcare, the
costs of getting to clinics are usually borne by the patient. Travel
© 2020 The Authors. European Journal of Heart Failure published by John Wiley & Sons Ltd on behalf of European Society of Cardiology.
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Table 1 Actionable measurements and interventions required for care of patients with heart failure
ACEi, angiotensin-converting enzyme inhibitor; AF, atrial fibrillation; ARB, angiotensin receptor blocker; ARNI, angiotensin receptor–neprilysin inhibitor; BNP, B-type
natriuretic peptide; BP, blood pressure; CRT, cardiac resynchronisation therapy; Echo, echocardiography; GFR, glomerular filtration rate; HR, heart rate; ICD, implantable
cardioverter-defibrillator; K+ , serum potassium; MRA, mineralocorticoid receptor antagonist; OAC, oral anti-coagulant; QRS, QRS width on the electrocardiogram;
Revascularisation, coronary revascularisation; SGLT2i, sodium–glucose co-transporter 2 inhibitor; SOB, shortness of breath; Valve, valve procedure– mitral or aortic.
✓= required for monitoring during follow-up; I = mainly for deciding on initiation or investigation; R? = consider reducing or temporarily stopping.
Black = currently widely available technologies (e.g.: ECG/sphygmomanometer). Blue = technology with limited availability for use at home (e.g. bio-impedance, blood tests).
Echo is in purple, because although home monitoring is unlikely in the near future, it plays an essential role in identifying reduced left ventricular ejection fraction and valve
disease and therefore in treatment selection.
*Water retention leading to oedema (an increase in water in the tissues). Detection and treatment of subclinical oedema can prevent symptoms and improve prognosis.
#BNP is a useful marker of poorly controlled congestion/heart failure and the need for further investigation/treatment.
to and waiting at a clinic can easily take up most of a patient’s day.
Other hidden costs include air pollution and traffic congestion and
the costs of building clinic space and carparks. Also, telemonitor-
ing requires an associated electronic health record that enables
machine learning that can generate advice for both patients and
health professionals. Clearly, some people will feel uncomfortable
about their data being used like this, but their concerns should
not deny benefit to others. Informed patients should choose who
has access to their data and for what purpose. This could benefit
billions of people worldwide. Regulations that pay more attention
to the worried-well than to patients who are in need must be
avoided. The pandemic has shown us the public’s view on this
issue.
In summary, adoption of home telemonitoring as a routine clin-
ical service for most medical problems will improve the efficiency
and quality of care, reduce demands on patients, and reduce health-
care costs and environmental pollution. It will also reduce the
spread of infections, whether that is the misery of seasonal rhi-
novirus, annual influenza, or a lethal pandemic. Let’s do it—now!
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